Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference (original) (raw)

• Anderson L, Henderson C, Adachi Y . (2001). Phosphorylation and rapid relocalization of 53BP1 to nuclear foci upon DNA damage. Mol Cell Biol 21: 1719–1729.
  Article CAS PubMed PubMed Central Google Scholar
• Blow JJ, Hodgson B . (2002). Replication licensing – defining the proliferative state? Trends Cell Biol 12: 72–78.
  Article CAS PubMed PubMed Central Google Scholar
• Brachner A, Sasgary S, Pirker C, Rodgarkia C, Mikula M, Mikulits W et al. (2006). Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT. Cancer Res 66: 3584–3592.
  Article CAS PubMed Google Scholar
• Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR . (1997). Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3: 1271–1274.
  Article CAS PubMed Google Scholar
• Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR . (1995). Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14: 4240–4248.
  Article CAS PubMed PubMed Central Google Scholar
• Cerone MA, Autexier C, Londono-Vallejo JA, Bacchetti S . (2005). A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT. Oncogene 24: 7893–7901.
  Article CAS PubMed Google Scholar
• de Lange T . (2002). Protection of mammalian telomeres. Oncogene 21: 532–540.
  Article CAS PubMed Google Scholar
• de Lange T . (2005). Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19: 2100–2110.
  Article CAS PubMed Google Scholar
• Dunham MA, Neumann AA, Fasching CL, Reddel RR . (2000). Telomere maintenance by recombination in human cells. Nat Genet 26: 447–450.
  Article CAS PubMed Google Scholar
• Fasching CL, Bower K, Reddel RR . (2005). Telomerase-independent telomere length maintenance in the absence of ALT-associated PML bodies. Cancer Res 65: 2722–2729.
  Article CAS PubMed Google Scholar
• Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H . (1984). Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710–1715.
  CAS PubMed Google Scholar
• Gerdes J, Schwab U, Lemke H, Stein H . (1983). Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13–20.
  Article CAS PubMed Google Scholar
• Goldberg M, Stucki M, Falck J, D'Amours D, Rahman D, Pappin D et al. (2003). MDC1 is required for the intra-S-phase DNA damage checkpoint. Nature 421: 952–956.
  Article CAS PubMed Google Scholar
• Gonzalo S, Jaco I, Fraga MF, Chen T, Li E, Esteller M et al. (2006). DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol 8: 416–424.
  Article CAS PubMed Google Scholar
• Greider CW, Blackburn EH . (1985). Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43: 405–413.
  Article CAS PubMed Google Scholar
• Grobelny JV, Godwin AK, Broccoli D . (2000). ALT-associated PML bodies are present in viable cells and are enriched in cells in the G2/M phase of the cell cycle. J Cell Sci 113: 4577–4585.
  CAS PubMed Google Scholar
• Halpern BC, Clark BR, Hardy DN, Halpern RM, Smith RA . (1974). The effect of replacement of methionine by homocystine on survival of malignant and normal adult mammalian cells in culture. Proc Natl Acad Sci USA 71: 1133–1136.
  Article CAS PubMed Google Scholar
• Henson JD, Hannay JA, McCarthy SW, Royds JA, Yeager TR, Robinson RA et al. (2005). A robust assay for alternative lengthening of telomeres (ALT) in tumors demonstrates the significance of ALT in sarcomas and astrocytomas. Clin Cancer Res 11: 217–225.
  CAS PubMed Google Scholar
• Houghtaling BR, Cuttonaro L, Chang W, Smith S . (2004). A dynamic molecular link between the telomere length regulator TRF1 and the chromosome end protector TRF2. Curr Biol 14: 1621–1631.
  Article CAS PubMed Google Scholar
• Iwabuchi K, Bartel PL, Li B, Marraccino R, Fields S . (1994). Two cellular proteins that bind to wild-type but not mutant p53. Proc Natl Acad Sci USA 91: 6098–6102.
  Article CAS PubMed Google Scholar
• Jiang WQ, Zhong ZH, Henson JD, Neumann AA, Chang AC, Reddel RR . (2005). Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of MRE11/RAD50/NBS1 complex. Mol Cell Biol 25: 2708–2721.
  Article CAS PubMed PubMed Central Google Scholar
• Johnson FB, Marciniak RA, McVey M, Stewart SA, Hahn WC, Guarente L . (2001). The Saccharomyces cerevisiae WRN homolog Sgs1p participates in telomere maintenance in cells lacking telomerase. EMBO J 20: 905–913.
  Article CAS PubMed PubMed Central Google Scholar
• Judde JG, Ellis M, Frost P . (1989). Biochemical analysis of the role of transmethylation in the methionine dependence of tumor cells. Cancer Res 49: 4859–4865.
  CAS PubMed Google Scholar
• Kamei H . (1996). Reversible large-body formation from nuclear bodies upon amino acid(s) starvation in T24 cells. Exp Cell Res 224: 302–311.
  Article CAS PubMed Google Scholar
• Kamei H . (1997). Cystine starvation induces reversible large-body formation from nuclear bodies in T24 cells. Exp Cell Res 237: 207–216.
  Article CAS PubMed Google Scholar
• Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T . (1999). p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283: 1321–1325.
  Article CAS PubMed Google Scholar
• Kim SH, Beausejour C, Davalos AR, Kaminker P, Heo SJ, Campisi J . (2004). TIN2 mediates functions of TRF2 at human telomeres. J Biol Chem 279: 43799–43804.
  Article CAS PubMed Google Scholar
• Lei M, Tye BK . (2001). Initiating DNA synthesis: from recruiting to activating the MCM complex. J Cell Sci 114: 1447–1454.
  CAS PubMed Google Scholar
• Li B, de Lange T . (2003). Rap1 affects the length and heterogeneity of human telomeres. Mol Biol Cell 14: 5060–5068.
  Article CAS PubMed PubMed Central Google Scholar
• Li B, Oestreich S, de Lange T . (2000). Identification of human Rap1: implications for telomere evolution. Cell 101: 471–483.
  Article CAS PubMed Google Scholar
• Lu S, Epner DE . (2000). Molecular mechanisms of cell cycle block by methionine restriction in human prostate cancer cells. Nutr Cancer 38: 123–130.
  Article CAS PubMed Google Scholar
• Marciniak RA, Cavazos D, Montellano R, Chen Q, Guarente L, Johnson FB . (2005). A novel telomere structure in human alternative lengthening of telomeres cell line. Cancer Res 65: 2730–2737.
  Article CAS PubMed Google Scholar
• Mecham JO, Rowitch D, Wallace CD, Stern PH, Hoffman RM . (1983). The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem Biophys Res Commun 117: 429–434.
  Article CAS PubMed Google Scholar
• Molenaar C, Wiesmeijer K, Verwoerd NP, Khazen S, Eils R, Tanke HJ et al. (2003). Visualizing telomere dynamics in living mammalian cells using PNA probes. EMBO J 22: 6631–6641.
  Article CAS PubMed PubMed Central Google Scholar
• Moran-Jones K, Wayman L, Kennedy DD, Reddel RR, Sara S, Snee MJ et al. (2005). hnRNP A2, a potential ssDNA/RNA molecular adapter at the telomere. Nucleic Acids Res 33: 486–496.
  Article CAS PubMed PubMed Central Google Scholar
• Murnane JP, Sabatier L, Marder BA, Morgan WF . (1994). Telomere dynamics in an immortal human cell line. EMBO J 13: 4953–4962.
  Article CAS PubMed PubMed Central Google Scholar
• Nabetani A, Yokoyama O, Ishikawa F . (2004). Localization of hRad9, hHus1, hRad1 and hRad17, and caffeine-sensitive DNA replication at ALT (alternative lengthening of telomeres)-associated promyelocytic leukemia body. J Biol Chem 279: 25849–25857.
  Article CAS PubMed Google Scholar
• O'Connor MS, Safari A, Liu D, Qin J, Songyang Z . (2004). The human Rap1 protein complex and modulation of telomere length. J Biol Chem 279: 28585–28591.
  Article CAS PubMed Google Scholar
• Pavillard V, Drbal AA, Swaine DJ, Phillips RM, Double JA, Nicolaou A . (2004). Analysis of cell-cycle kinetics and sulfur amino acid metabolism in methionine-dependent tumor cell lines; the effect of homocysteine supplementation. Biochem Pharmacol 67: 1587–1599.
  Article CAS PubMed Google Scholar
• Perrem K, Colgin LM, Neumann AA, Yeager TR, Reddel RR . (2001). Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol Cell Biol 21: 3862–3875.
  Article CAS PubMed PubMed Central Google Scholar
• Rappold I, Iwabuchi K, Date T, Chen J . (2001). Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways. J Cell Biol 153: 613–620.
  Article CAS PubMed PubMed Central Google Scholar
• Rogan EM, Bryan TM, Hukku B, Maclean K, Chang ACM, Moy EL et al. (1995). Alterations in p53 and p16_INK4_ expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol Cell Biol 15: 4745–4753.
  Article CAS PubMed PubMed Central Google Scholar
• Schultz LB, Chehab NH, Malikzay A, Halazonetis TD . (2000). p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J Cell Biol 151: 1381–1390.
  Article CAS PubMed PubMed Central Google Scholar
• Silverman J, Takai H, Buonomo SB, Eisenhaber F, de Lange T . (2004). Human Rif1, ortholog of a yeast telomeric protein, is regulated by ATM and 53BP1 and functions in the S-phase checkpoint. Genes Dev 18: 2108–2119.
  Article CAS PubMed PubMed Central Google Scholar
• Smyth CM, Helmer MA, Dalla-Pozza L, Rowe PB . (1993). Flow cytometric DNA analyses of frozen samples from children's solid tumors. Pathology 25: 388–393.
  Article CAS PubMed Google Scholar
• Stavropoulos DJ, Bradshaw PS, Li X, Pasic I, Truong K, Ikura M et al. (2002). The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis. Hum Mol Genet 11: 3135–3144.
  Article CAS PubMed Google Scholar
• Stern PH, Hoffman RM . (1984). Elevated overall rates of transmethylation in cell lines from diverse human tumors. In Vitro 20: 663–670.
  Article CAS PubMed Google Scholar
• Stern PH, Hoffman RM . (1986). Enhanced in vitro selective toxicity of chemotherapeutic agents for human cancer cells based on a metabolic defect. J Natl Cancer Inst 76: 629–639.
  Article CAS PubMed Google Scholar
• Takai H, Smogorzewska A, de Lange T . (2003). DNA damage foci at dysfunctional telomeres. Curr Biol 13: 1549–1556.
  Article CAS PubMed Google Scholar
• Tarsounas M, Munoz P, Claas A, Smiraldo PG, Pittman DL, Blasco MA et al. (2004). Telomere maintenance requires the RAD51D recombination/repair protein. Cell 117: 337–347.
  Article CAS PubMed Google Scholar
• Tisdale MJ . (1980). Effect of methionine deprivation on methylation and synthesis of macromolecules. Br J Cancer 42: 121–128.
  Article CAS PubMed PubMed Central Google Scholar
• Toouli CD, Huschtscha LI, Neumann AA, Noble JR, Colgin LM, Hukku B et al. (2002). Comparison of human mammary epithelial cells immortalized by simian virus 40 T-Antigen or by the telomerase catalytic subunit. Oncogene 21: 128–139.
  Article CAS PubMed Google Scholar
• van Steensel B, de Lange T . (1997). Control of telomere length by the human telomeric protein TRF1. Nature 385: 740–743.
  Article CAS PubMed Google Scholar
• van Steensel B, Smogorzewska A, de Lange T . (1998). TRF2 protects human telomeres from end-to-end fusions. Cell 92: 401–413.
  Article CAS PubMed Google Scholar
• Wang RC, Smogorzewska A, de Lange T . (2004). Homologous recombination generates T-loop-sized deletions at human telomeres. Cell 119: 355–368.
  Article CAS PubMed Google Scholar
• Wu G, Jiang X, Lee WH, Chen PL . (2003). Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen breakage syndrome 1. Cancer Res 63: 2589–2595.
  CAS PubMed Google Scholar
• Wu G, Lee WH, Chen PL . (2000). NBS1 and TRF1 colocalize at promyelocytic leukemia bodies during late S/G2 phrases in immortalized telomerase-negative cells. Implication of NBS1 in alternative lengthening of telomeres. J Biol Chem 275: 30618–30622.
  Article CAS PubMed Google Scholar
• Xu L, Blackburn EH . (2004). Human Rif1 protein binds aberrant telomeres and aligns along anaphase midzone microtubules. J Cell Biol 167: 819–830.
  Article CAS PubMed PubMed Central Google Scholar
• Xu ZX, Timanova-Atanasova A, Zhao RX, Chang KS . (2003). PML colocalizes with and stabilizes the DNA damage response protein TopBP1. Mol Cell Biol 23: 4247–4256.
  Article CAS PubMed PubMed Central Google Scholar
• Yankiwski V, Marciniak RA, Guarente L, Neff NF . (2000). Nuclear structure in normal and Bloom syndrome cells. Proc Natl Acad Sci USA 97: 5214–5219.
  Article CAS PubMed Google Scholar
• Ye JZ, de Lange T . (2004). TIN2 is a tankyrase 1 PARP modulator in the TRF1 telomere length control complex. Nat Genet 36: 618–623.
  Article CAS PubMed Google Scholar
• Ye JZ, Donigian JR, Van Overbeek M, Loayza D, Luo Y, Krutchinsky AN et al. (2004). TIN2 binds TRF1 and TRF2 simultaneously and stabilizes the TRF2 complex on telomeres. J Biol Chem 279: 47264–47271.
  Article CAS PubMed Google Scholar
• Yeager TR, Neumann AA, Englezou A, Huschtscha LI, Noble JR, Reddel RR . (1999). Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res 59: 4175–4179.
  CAS PubMed Google Scholar
• Zhu XD, Kuster B, Mann M, Petrini JH, de Lange T . (2000). Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres. Nat Genet 25: 347–352.
  Article CAS PubMed Google Scholar
• Zhu XD, Niedernhofer L, Kuster B, Mann M, Hoeijmakers JH, de Lange T . (2003). ERCC1/XPF removes the 3′ overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol Cell 12: 1489–1498.
  Article CAS PubMed Google Scholar